News
13h
Pharmaceutical Technology on MSNUS government exercises $144m option for smallpox/mpox vaccine contractThe options are for the freeze-dried version of Bavarian Nordic’s Jynneos, a formulation that allows easier stockpiling.
The freeze-dried formulation will be easier to store and transport than the liquid-frozen formulation that Bavarian Nordic ...
Exercised options total USD 143.6 million <li /> Secures manufacturing and supply of freeze-dried JYNNEOS® to the U.S. in 20 ...
Bavarian Nordic's own pipeline is led by its universal COVID-19 booster candidate, which is due to start phase 3 later this year, and respiratory syncytial virus (RSV) candidate that should ...
Get Bavarian Nordic A/S alerts: Bavarian Nordic A/S (OTCMKTS:BVNRY – Get Free Report) last issued its quarterly earnings data on Wednesday, March 5th. The company reported $0.47 earnings per ...
Copenhagen, Denmark Saturday, May 3, 2025, 12:00 Hrs [IST] ...
Bavarian Nordic is a developer and provider of vaccines for public health and travel immunizations. This way, BVNKF helps prevent the spread of infectious diseases across borders. They’re ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Bavarian Nordic A/S (OMX: BAVA) announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has ...
(MENAFN- GlobeNewsWire - Nasdaq) COPENHAGEN, Denmark, May 2, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results